Related Headlines Researchers develop a new brain-computer interface that can mimic the brain of a human for a new type of medical test article Researchers in Japan are developing a new system that could one day be used to detect brain damage in patients who are blind.
The Japanese researchers said the device could be used in patients with traumatic brain injury, stroke or Alzheimer’s disease to assess their cognitive functions.
The new device could provide a new way to monitor brain function during surgeries.
The device, called a fMRI, is made of a silicon chip with an electrode placed over the top of it.
A camera on top takes pictures of the electrode, which is then stored on an external hard drive.
The camera can be used for long-term storage of brain scans.
The researchers said they expect to have the device ready to go within three to five years.
The devices use a laser and an electron microscope to look at the brain’s electrical activity.
They are also capable of scanning blood vessels, which can provide images of blood flow in the brain.
The first patients to receive the device are expected to be in the next few months, said Yosuke Tanaka, the senior director of research at the Center for Neurotechnology.
The researchers hope to test the device on more than 1,000 patients.
The project has been a success so far, Tanaka said.
The device has been able to identify abnormal brain activity in 20 percent of patients and show that abnormal activity is a sign of brain damage.
The fMRI device has not been able yet to do so with other types of tests, such as electroencephalography, which measures electrical activity in the brains of patients.
That type of testing, however, is only useful in patients for a certain time.
The study, which was published in the journal Science Translational Medicine, has shown the device can detect brain activity more accurately than existing technologies such as magnetic resonance imaging and positron emission tomography.
The technology is designed to look for abnormal brain waves in patients at a lower threshold of detection, said Toshihiro Hasegawa, the lead author of the study.
This means that it can be more effective at detecting abnormalities in the body than the MRI and positrons.
For example, the researchers were able to detect abnormalities in blood flow at a threshold of 10 micrograms per milliliter, which indicates a level of brain inflammation.
The new technology has also shown more precise diagnostic accuracy, Tanaka added.
For example, it has been possible to detect abnormal activity in blood vessels with a threshold at 1 microgram, which suggests a level more than one micrometer below normal brain function.
This study is the first time that researchers have used a fMRIs technology to analyze brain activity, said Takashi Yamada, the co-senior author of that study.
That technology is used to analyze blood flow during surgeries, which also requires careful monitoring.
The technique could help doctors identify patients who have had surgery, and may help them to find out if they might have an underlying condition.
However, this is not the first method of measuring brain activity that has been tested.
Scientists in Japan have used fMRI to test for dementia and brain disease in patients undergoing brain surgery.
The current study was not designed to compare the devices performance with current technologies.
It was designed to test their new technology against existing technologies.
The research was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Foundation for Research and Technology and the Japan Society for the Advancement of Science and Mathematics.
The research was published online in Science Transm Med.
More content from NBCNews.com: